Nosocomial antibiotic resistance in multiple gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites

Clinical Infectious Diseases

Volumn 34, Issue 4, 2002, Pages 499-503

  Rahal, James J ^a   Urban, Carl ^a   Segal Maurer, Sorana ^a  

^a NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLONE DERIVATIVE; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; EDUCATION PROGRAM; ENDEMIC DISEASE; EPIDEMIC; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MULTIDRUG RESISTANCE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; R FACTOR;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0037083034     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338639     Document Type: Article

References (27)

1. 4th Decennial international conference on nosocomial and healthcare-associated infections. March 5-9, 2000. Atlanta, Georgia: Proceedings
2. Antibiotic resistance in the intensive care unit
3. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes
4. Surveillance of antimicrobial use and resistance in United States hospitals: Project ICARE phase 2
5. Antibiotic resistance - Squeezing the balloon
6. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins
7. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae
8. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
9. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-I, a plasmid-mediated AmpC β-lactamase and the loss of an outer membrane protein
10. Clinical and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae
11. Class withdrawal of cephalosporins for control of total cephalosporin resistance in nosocomial Klebsiella
12. Imipenem-resistant (IR) Pseudomonas aeruginosa (PA) in Brooklyn, NY: Prevalence and molecular epidemiology
13. Of Pseudomonas, porins, pumps and carbapenems
14. Multiple antibiotic-resistant bacteria in long-term care facilities: An emerging problem in the practice of infectious diseases
15. SHV-7, a novel cefotaxime-hydrolysing β-lactamase in Escherichia coli isolates from hospitalized nursing home patients
16. Outbreak of clonal ceftazidime-resistant Klebsiella pneumoniae bacteremia in a surgical intensive care unit: A case-control study
17. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory
18. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
19. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the STERIS System 1 Processor
20. Carbapenemases: A problem in waiting?
21. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin
22. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem
23. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein
24. Carbapenem resistance in a clinical isolate of Citrobacter freundii
25. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership
26. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance guidelines for the prevention of antimicrobial resistance in hospitals